cell bank / immune privileged site / intended cell-based product / cell-based product / investigational medicinal products / cell-based products / administered cellular product / media composition / final products / implanted cell products / cell banking / medicinal products / therapy medicinal product / cell containing medicinal products / manufacturing process / administered stem cell product / stem-cell based product / consistent and reproducible final product / final product / therapy medicinal products / treatment of cancer / manufacturing steps / human cell-based medicinal products / medicinal product / stem cell product / manufacturing / manufacturing process in vitro assessment / therapeutic applications / cell-based medicinal products / /
MedicalCondition
teratomas / form teratomas / therapeutic indication i.e. disease / injury / malignant teratocarcinomas / Potential inflammatory / permissive host form teratomas / Teratoma / cancer / tumour / chronic disease / diseases / inflammation / degenerative and inflammatory diseases / tumours / /
MedicalTreatment
chemotherapy / Cell therapy / /
Organization
Committee for Advanced Therapies / E-mail info@ema.europa.eu Website www.ema.europa.eu An / European Medicines Agency / Biologics Working Party / Cell Products Working Party / Safety Working Party / European Union / / /
14 January 2011 EMA/CAT[removed]Committee for Advanced Therapies (CAT) Reflection paper on stem cell-based medicinal products